Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Role of nuclear receptors in lipid dysfunction and obesity-related diseases.

Swanson HI, Wada T, Xie W, Renga B, Zampella A, Distrutti E, Fiorucci S, Kong B, Thomas AM, Guo GL, Narayanan R, Yepuru M, Dalton JT, Chiang JY.

Drug Metab Dispos. 2013 Jan;41(1):1-11. doi: 10.1124/dmd.112.048694. Epub 2012 Oct 4.

2.

Nuclear receptors in bile acid metabolism.

Li T, Chiang JY.

Drug Metab Rev. 2013 Feb;45(1):145-55. doi: 10.3109/03602532.2012.740048. Review.

3.

Regulation of hepatic drug metabolism: role of the nuclear receptors PXR and CAR.

Liddle C, Goodwin B.

Semin Liver Dis. 2002;22(2):115-22. Review.

PMID:
12016543
4.

Bile acid-activated receptors in the treatment of dyslipidemia and related disorders.

Fiorucci S, Cipriani S, Baldelli F, Mencarelli A.

Prog Lipid Res. 2010 Apr;49(2):171-85. doi: 10.1016/j.plipres.2009.11.001. Epub 2009 Dec 2. Review.

PMID:
19932133
5.

Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.

Guo GL, Lambert G, Negishi M, Ward JM, Brewer HB Jr, Kliewer SA, Gonzalez FJ, Sinal CJ.

J Biol Chem. 2003 Nov 14;278(46):45062-71. Epub 2003 Aug 15.

6.

Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism.

Gao J, Xie W.

Drug Metab Dispos. 2010 Dec;38(12):2091-5. doi: 10.1124/dmd.110.035568. Epub 2010 Aug 24. Review.

7.
8.

PXR and CAR in energy metabolism.

Wada T, Gao J, Xie W.

Trends Endocrinol Metab. 2009 Aug;20(6):273-9. doi: 10.1016/j.tem.2009.03.003. Review.

PMID:
19595610
9.

The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.

Kliewer SA, Lehmann JM, Milburn MV, Willson TM.

Recent Prog Horm Res. 1999;54:345-67; discussion 367-8. Review.

PMID:
10548883
10.

Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond.

Chai X, Zeng S, Xie W.

Expert Opin Drug Metab Toxicol. 2013 Mar;9(3):253-66. doi: 10.1517/17425255.2013.754010. Epub 2013 Jan 17. Review.

PMID:
23327618
11.

Induction of phase I, II and III drug metabolism/transport by xenobiotics.

Xu C, Li CY, Kong AN.

Arch Pharm Res. 2005 Mar;28(3):249-68. Review.

PMID:
15832810
12.

[Farnesoid X receptor regulates glucose and lipid metabolisms].

Jiang Q, Peng J, Liu SN, Shen ZF.

Yao Xue Xue Bao. 2015 Mar;50(3):245-51. Chinese.

PMID:
26118101
13.

FXR signaling in metabolic disease.

Zhang Y, Edwards PA.

FEBS Lett. 2008 Jan 9;582(1):10-8. Epub 2007 Nov 20. Review.

14.

The role of bile acids in metabolic regulation.

Vítek L, Haluzík M.

J Endocrinol. 2016 Mar;228(3):R85-96. doi: 10.1530/JOE-15-0469. Epub 2016 Jan 5. Review.

15.

Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha.

Luo J, Sladek R, Carrier J, Bader JA, Richard D, Giguère V.

Mol Cell Biol. 2003 Nov;23(22):7947-56.

16.
17.

Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity.

Prawitt J, Abdelkarim M, Stroeve JH, Popescu I, Duez H, Velagapudi VR, Dumont J, Bouchaert E, van Dijk TH, Lucas A, Dorchies E, Daoudi M, Lestavel S, Gonzalez FJ, Oresic M, Cariou B, Kuipers F, Caron S, Staels B.

Diabetes. 2011 Jul;60(7):1861-71. doi: 10.2337/db11-0030. Epub 2011 May 18.

18.

Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor.

Kliewer SA, Willson TM.

J Lipid Res. 2002 Mar;43(3):359-64. Review.

19.

Nuclear bile acid signaling through the farnesoid X receptor.

Mazuy C, Helleboid A, Staels B, Lefebvre P.

Cell Mol Life Sci. 2015 May;72(9):1631-50. doi: 10.1007/s00018-014-1805-y. Epub 2014 Dec 16. Review.

PMID:
25511198
20.

[Advances in the research of pregnane X receptor and constitutive androstane receptor].

Hu BF, Bi HC, Huang M.

Yao Xue Xue Bao. 2011 Oct;46(10):1173-7. Review. Chinese.

PMID:
22242446

Supplemental Content

Support Center